AU2002239697A1 - Sodium hyaluronate microspheres - Google Patents

Sodium hyaluronate microspheres

Info

Publication number: AU2002239697A1
Authority: AU; Australia
Prior art keywords: sodium hyaluronate; hyaluronate microspheres; microspheres; sodium; hyaluronate
Prior art date: 2000-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002239697A

Inventor

Philip Dehazya

Cheng Lu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Clear Solutions Biotech Inc

Original Assignee

Clear Solutions Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-24

Filing date

2001-10-24

Publication date

2002-06-03

2001-10-24 Application filed by Clear Solutions Biotech Inc filed Critical Clear Solutions Biotech Inc

2002-06-03 Publication of AU2002239697A1 publication Critical patent/AU2002239697A1/en

Status Abandoned legal-status Critical Current

Links

229920002385 Sodium hyaluronate Polymers 0.000 title 1
239000004005 microsphere Substances 0.000 title 1
229940010747 sodium hyaluronate Drugs 0.000 title 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AU2002239697A 2000-10-24 2001-10-24 Sodium hyaluronate microspheres Abandoned AU2002239697A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US69544500A	2000-10-24	2000-10-24
US09695445		2000-10-24
PCT/US2001/050183 WO2002041877A1 (en)	2000-10-24	2001-10-24	Sodium hyaluronate microspheres

Publications (1)

Publication Number	Publication Date
AU2002239697A1 true AU2002239697A1 (en)	2002-06-03

Family

ID=24792994

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002239697A Abandoned AU2002239697A1 (en)	2000-10-24	2001-10-24	Sodium hyaluronate microspheres

Country Status (3)

Country	Link
US (2)	US20030096734A1 (en)
AU (1)	AU2002239697A1 (en)
WO (1)	WO2002041877A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7425543B2 (en) *	1992-11-16	2008-09-16	The Corporation Of Mercer University	Microencapsulated materials and method of making same
US7700819B2 (en)	2001-02-16	2010-04-20	Kci Licensing, Inc.	Biocompatible wound dressing
US7763769B2 (en)	2001-02-16	2010-07-27	Kci Licensing, Inc.	Biocompatible wound dressing
GB0129489D0 (en) *	2001-12-10	2002-01-30	Quadrant Healthcare Uk Ltd	Sustained-release compositions
ITPD20020003A1 (en) *	2002-01-11	2003-07-11	Fidia Advanced Biopolymers Srl	BIOMATERIALS BASED ON HYALURONIC ACID AS ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT.
AU2003299509A1 (en)	2002-06-21	2004-05-13	University Of Utah Research Foundation	Crosslinked compounds and methods of making and using thereof
GB2408207A (en) *	2003-11-24	2005-05-25	Johnson & Johnson Medical Ltd	Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
US20050215516A1 (en) *	2004-03-29	2005-09-29	Claudio Bucolo	New free-radical scavenger containing viscoelastic composition, methods of use and package
ITRM20040318A1 (en) *	2004-06-28	2004-09-28	Univ Palermo	HYALURONIC AND ALPHA HYDROGEL, BETA-POLYASPARTYL HYDRAZIDE AND THEIR BIOMEDICAL AND PHARMACEUTICAL APPLICATIONS.
CN101217946B (en) *	2004-11-02	2012-11-07	特拉维夫大学未来技术研发有限公司	Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use
WO2006113668A1 (en) *	2005-04-15	2006-10-26	University Of South Florida	A method of transdermal drug delivery using hyaluronic acid nanoparticles
EP1926459B1 (en)	2005-09-19	2015-01-07	Histogenics Corporation	Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
CA2645227C (en)	2006-03-07	2015-06-23	Prochon Biotech Ltd.	Hydrazido derivatives of hyaluronic acid
EP1992332A1 (en) *	2007-05-08	2008-11-19	Tupperware Products S.A.	Cosmetic anti ageing skin care compositions
US9295621B2 (en) *	2007-07-31	2016-03-29	Elc Management Llc	Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US8080583B2 (en)	2007-07-31	2011-12-20	Elc Management Llc	Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US20090035240A1 (en) *	2007-07-31	2009-02-05	Maes Daniel H	Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US20090035236A1 (en) *	2007-07-31	2009-02-05	Maes Daniel H	Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US8344024B2 (en) *	2007-07-31	2013-01-01	Elc Management Llc	Anhydrous cosmetic compositions containing resveratrol derivatives
US8563514B2 (en) *	2007-08-15	2013-10-22	Metamorefix	Peptides and pharmaceutical compositions for treating connective tissue
US20090068132A1 (en) *	2007-09-08	2009-03-12	Daniela Bratescu	Resveratrol Ferulate Compounds, Compositions Containing The Compounds, And Methods Of Using The Same
CN101878230B (en) *	2007-12-19	2012-11-21	赢创高施米特有限公司	Cross-Linked Hyaluronic Acid in Emulsion
US20090285866A1 (en) *	2008-05-13	2009-11-19	Afriat Isabelle R	Self-healing polymer compositions
US20100136070A1 (en) *	2008-12-03	2010-06-03	Jakk Group, Inc.	Methods, devices, and compositions for dermal filling
US8263069B2 (en)	2008-12-31	2012-09-11	Johnson Lanny L	Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
US8197849B2 (en) *	2010-02-12	2012-06-12	National Health Research Institutes	Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
US10865383B2 (en)	2011-07-12	2020-12-15	Lineage Cell Therapeutics, Inc.	Methods and formulations for orthopedic cell therapy
CN103181902B (en) *	2011-12-30	2016-06-08	张文芳	A kind of gel micro-ball and quality control method thereof
FR2997406B1 (en) *	2012-10-25	2015-07-03	Basf Beauty Care Solutions F	HYALURONATE AND GLUCOMANNAN POLYMER
CN103041448B (en) *	2013-01-17	2015-09-23	苏州博创同康生物工程有限公司	A kind of compound polysaccharide hemostatic material and its preparation method and application
US9968623B2 (en)	2013-08-29	2018-05-15	Lanny Leo Johnson	Prepackaged sterile syringe or containers with various substance concentrations with or without bioactive reagent
US10077420B2 (en)	2014-12-02	2018-09-18	Histogenics Corporation	Cell and tissue culture container
CN108403644B (en) *	2018-03-16	2020-08-14	安徽工程大学	Anticancer medicine nano microsphere and its preparation method
IT201800008192A1 (en) *	2018-08-27	2020-02-27	Ira St Ricerche Applicate Spa	MICROSPHERES OF HYALURONIC ACID CROSS-LINKED WITH UREA AND CONTAINING AT LEAST ONE ACTIVE AGENT OR DRUG
CN111686664B (en) *	2019-03-13	2022-10-28	杭州协合医疗用品有限公司	Emulsified cross-linked sodium hyaluronate gel microsphere for injection and preparation method thereof
KR102501175B1 (en) *	2020-02-03	2023-02-16	엠앤에이치바이오 주식회사	Controlled release formulations for treating hearing loss and method of preparing the same
CN111848991B (en) *	2020-07-21	2022-03-29	华熙生物科技股份有限公司	Preparation method of crosslinked hyaluronic acid microspheres
CN115850737A (en) *	2022-11-25	2023-03-28	尚诚怡美(成都)生物科技有限公司	A method for preparing cross-linked hyaluronic acid microspheres by spray method
CN115918908B (en) *	2022-12-20	2024-12-06	济宁医学院附属医院	Rapidly soluble sodium hyaluronate, preparation method, application and product
CN117018288B (en) *	2023-07-28	2025-10-03	四川大学	A preparation method of hyaluronic acid microspheres for injection
WO2025175323A1 (en) *	2024-02-12	2025-08-21	Ascentx Medical, Inc.	Compositions and methods of suspended hyaluronic acid microspheres for tissue and skin regeneration, augmentation, repair, and adjustment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5128326A (en)	1984-12-06	1992-07-07	Biomatrix, Inc.	Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4851521A (en)	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
IT1198449B (en) *	1986-10-13	1988-12-21	F I D I Farmaceutici Italiani	ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
US5690954A (en)	1987-05-22	1997-11-25	Danbiosyst Uk Limited	Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB2281861B (en)	1993-09-21	1997-08-20	Johnson & Johnson Medical	Bioabsorbable wound implant materials containing microspheres
US5766632A (en) *	1993-10-01	1998-06-16	Legere Pharmaceuticals, Ltd.	Method of using lectins for contraception
US5616568A (en)	1993-11-30	1997-04-01	The Research Foundation Of State University Of New York	Functionalized derivatives of hyaluronic acid
US6071535A (en)	1996-01-31	2000-06-06	Collaborative Laboratories, Inc.	Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en)	1996-01-31	1999-02-23	Collaborative Laboratories, Inc.	Lipid vesicles formed with alkylammonium fatty acid salts
AUPO888097A0 (en) *	1997-08-29	1997-09-25	Biotech Australia Pty Limited	Cross-linked particles
AU755465C (en) *	1998-06-01	2004-01-29	Fidia Farmaceutici S.P.A.	Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

2001
- 2001-10-24 AU AU2002239697A patent/AU2002239697A1/en not_active Abandoned
- 2001-10-24 WO PCT/US2001/050183 patent/WO2002041877A1/en not_active Ceased
2002
- 2002-12-05 US US10/310,629 patent/US20030096734A1/en not_active Abandoned
2003
- 2003-08-26 US US10/649,082 patent/US6969531B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20040127459A1 (en)	2004-07-01
US20030096734A1 (en)	2003-05-22
WO2002041877A1 (en)	2002-05-30
US6969531B2 (en)	2005-11-29

Publication	Publication Date	Title
AU2002239697A1 (en)	2002-06-03	Sodium hyaluronate microspheres
AU2001262237A1 (en)	2002-02-07	Reflector
EP1191039A4 (en)	2002-08-14	Polysaccharide derivative
AU4125001A (en)	2001-09-24	Computer case
AU2001282481A1 (en)	2002-03-13	Articulated structure
AU2001293297A1 (en)	2002-04-02	Phyisological profiling
EP1151667A3 (en)	2003-01-29	Plant-activating agent
AU2000254982A1 (en)	2002-01-02	Instrumented stent
AU7431901A (en)	2002-01-02	Coherence-free cache
AU2120200A (en)	2000-08-18	Cache memory
AU2001241512A1 (en)	2001-09-24	Sulfonamide derivatives
AU1554301A (en)	2001-06-12	Radioprotecting agent
AU2001296289A1 (en)	2002-04-08	Enhanced browsing environment
AU2001259272A1 (en)	2001-11-12	Viscometer
AU2001247447A1 (en)	2001-10-30	Mocvd-grown emode higfet buffer
EP1201403A3 (en)	2003-01-29	Electrofusible units
AU3809500A (en)	2000-09-28	Expression
AU2001275516A1 (en)	2001-12-17	Sodium-free chondroitin
AU3586501A (en)	2001-09-17	Computer network
AU2001296039A1 (en)	2002-04-15	Computer
AU2001277461A1 (en)	2002-01-02	Hinge
AU2000261825A1 (en)	2002-02-13	Protruding structure block
AU2738800A (en)	2000-08-18	Solid anti-galling agent
AU6759601A (en)	2001-12-24	Well
AU3816400A (en)	2001-10-15	Structure